Mandatory notification of intra group transfer of shares by primary insider’s related party
Nykode Therapeutics ASA (NYKD) · publisert 2021-10-12 16:18 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Elar Consulting AS 2 Details of the person discharging managerial responsibilities a) Name Lars Lund-Roland | – | disposal | 500 000 | 67,5 NOK | 2021-10-12 | NO0010714785 | MERK – Euronext Growth Oslo | rules |
| Elar Consulting AS 2 Details of the person discharging managerial responsibilities a) Name Lars Lund-Roland | – | acquisition | 500 000 | 67,5 NOK | 2021-10-12 | NO0010714785 | MERK – Euronext Growth Oslo | rules |
Vedlegg
- Attachment Elar.pdf (tekst hentet ut)
Meldingstekst
Elar Consulting AS has today sold 500,000 shares in Vaccibody AS to Elar Holding AS at NOK 67.5 per share. Following the transaction, Elar Consulting AS holds no shares and Elar Holding AS holds 500,000 shares in Vaccibody AS.
Elar Consulting AS is 50% owned by Lars Lund-Roland, member of the board of Vaccibody AS. Elar Holding AS is 100% owned by Elar Consulting AS.
Please see further details in attached document.